Lv12
40 积分 2023-08-29 加入
Framework nucleic acids as programmable carrier for transdermal drug delivery
1天前
待确认
DNA Framework-Enabled Ocular Barrier Penetration for Microinvasive Antiangiogenic Therapy
1天前
已完结
DNA-based biocomputing circuits and their biomedical applications
9天前
已完结
Albumin-based potential drugs: focus on half-life extension and nanoparticle preparation
11天前
已完结
Protein-based nanoparticles for drug delivery purposes
11天前
已完结
Albumin based versatile multifunctional nanocarriers for cancer therapy: Fabrication, surface modification, multimodal therapeutics and imaging approaches
11天前
已完结
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
11天前
已完结
FcRn: the neonatal Fc receptor comes of age
11天前
已完结
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
1个月前
已完结
Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact
1个月前
已完结
皖公网安备34019202002308
